Bullfrog AI Stock (NASDAQ:BFRG)

Revenue Financials Chart

Previous Close

$1.39

52W Range

$1.09 - $4.84

50D Avg

$1.36

200D Avg

$1.74

Market Cap

$14.24M

Avg Vol (3M)

$220.67K

Beta

0.56

Div Yield

BFRG Company Profile

BullFrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. It offers bfLEAP, an AI/ML platform for the analysis of preclinical and/or clinical data. The company also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of human cancer or neoplastic disease. BullFrog AI Holdings, Inc. was founded in 2017 and is based in Gaithersburg, Maryland.

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

Country

Employees

IPO Date

Feb 13, 2023

Website

BFRG Performance

BFRG Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	-	$65.00K	$10.00K
Operating Income	$-7.24M	$-5.37M	$-2.46M
Net Income	$-7.04M	$-5.36M	$-2.80M
EBITDA	$-7.24M	$-5.28M	$-2.45M
Basic EPS	$-0.85	$-0.89	$-0.46
Diluted EPS	$-0.85	$-0.89	$-0.46

Fiscal year ends in Dec 24 | Currency in USD

Peer Comparison

Ticker	Company
HCTI	Healthcare Triangle, Inc.
AYTU	Aytu BioPharma, Inc.
MBRX	Moleculin Biotech, Inc.
ATHA	Athira Pharma, Inc.
GOVX	GeoVax Labs, Inc.
NVNO	enVVeno Medical Corporation
XAIR	Beyond Air, Inc.
THAR	Tharimmune, Inc.
GLTO	Galecto, Inc.